Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP578887.RAY1ZAO3ky8vivnNS2Ir-MZhGLvfPYEFU4xgYF2aq0S3c130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578887.RAY1ZAO3ky8vivnNS2Ir-MZhGLvfPYEFU4xgYF2aq0S3c130_provenance.
• NP846095.RAZXX1RnxzQeT59huRpMY3aNjkkVBP-gv6-ziLHDvDAiw130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846095.RAZXX1RnxzQeT59huRpMY3aNjkkVBP-gv6-ziLHDvDAiw130_provenance.
• NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738114.RA72FBkEggyl2JMFe9XBZ9GcokVc1ppVanC3skgSpm4cE130_provenance.
• NP624465.RAcozwGlxv2PRrKaxoYvl4dvdjp7UHi6PoxJEqZArrj3M130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624465.RAcozwGlxv2PRrKaxoYvl4dvdjp7UHi6PoxJEqZArrj3M130_provenance.
• assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1073858.RAVLIq71JcZ8Gg-QskAUmVgxYuSA_1bsPtebzbxB47jus130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073858.RAVLIq71JcZ8Gg-QskAUmVgxYuSA_1bsPtebzbxB47jus130_provenance.
• NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.
• NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.
• NP625606.RA1mfeKrmoUXwyw57MK5MC9Qj7ox7EfFBS0gb-knRkk00130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625606.RA1mfeKrmoUXwyw57MK5MC9Qj7ox7EfFBS0gb-knRkk00130_provenance.
• NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073865.RALN7I64ClMVc3wbPdv16LSw8kfm1DjoB0gfNr-H2ubPU130_provenance.
• NP1073866.RAJaePHvQJW2sJy4rPmiwiYIsRvO2aFHkOeof_ONm8RBE130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073866.RAJaePHvQJW2sJy4rPmiwiYIsRvO2aFHkOeof_ONm8RBE130_provenance.
• NP1073867.RANsoJHJOC6W01l4ABCSvTxtB0TC3qwx53QVnL5Ou6fQw130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073867.RANsoJHJOC6W01l4ABCSvTxtB0TC3qwx53QVnL5Ou6fQw130_provenance.
• NP1073863.RA9o07-WOsYBKRLC71HGENaJTM94CscwsleGdwDKK6el4130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073863.RA9o07-WOsYBKRLC71HGENaJTM94CscwsleGdwDKK6el4130_provenance.
• NP1073864.RA6JwJOi1ZUlRInf5MAqNL8iKVkLqICZqdjb-eErQRm8g130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073864.RA6JwJOi1ZUlRInf5MAqNL8iKVkLqICZqdjb-eErQRm8g130_provenance.